Matches in Wikidata for { <http://www.wikidata.org/entity/Q96132781> ?p ?o ?g. }
Showing items 1 to 36 of
36
with 100 items per page.
- Q96132781 description "artículu científicu espublizáu en xunu de 2020" @default.
- Q96132781 description "im Juni 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q96132781 description "scientific article published on 01 June 2020" @default.
- Q96132781 description "wetenschappelijk artikel" @default.
- Q96132781 description "наукова стаття, опублікована 1 червня 2020" @default.
- Q96132781 name "Evidence Accumulates Against Angiotensin-Converting Enzyme Inhibitors and Beta-Adrenergic Blockers as Important Co-factors for Anaphylactic Reactions" @default.
- Q96132781 name "Evidence Accumulates Against Angiotensin-Converting Enzyme Inhibitors and Beta-Adrenergic Blockers as Important Co-factors for Anaphylactic Reactions" @default.
- Q96132781 type Item @default.
- Q96132781 label "Evidence Accumulates Against Angiotensin-Converting Enzyme Inhibitors and Beta-Adrenergic Blockers as Important Co-factors for Anaphylactic Reactions" @default.
- Q96132781 label "Evidence Accumulates Against Angiotensin-Converting Enzyme Inhibitors and Beta-Adrenergic Blockers as Important Co-factors for Anaphylactic Reactions" @default.
- Q96132781 prefLabel "Evidence Accumulates Against Angiotensin-Converting Enzyme Inhibitors and Beta-Adrenergic Blockers as Important Co-factors for Anaphylactic Reactions" @default.
- Q96132781 prefLabel "Evidence Accumulates Against Angiotensin-Converting Enzyme Inhibitors and Beta-Adrenergic Blockers as Important Co-factors for Anaphylactic Reactions" @default.
- Q96132781 P1433 Q96132781-53841535-9710-4E09-8847-405FF4E24D13 @default.
- Q96132781 P1476 Q96132781-0DBF56C2-3EEA-4E2C-95E5-EC6BE66C91DF @default.
- Q96132781 P2093 Q96132781-B965ADC8-891F-4F50-BE7B-0DEA6CBD6196 @default.
- Q96132781 P304 Q96132781-A6EC07FE-7CE3-4E38-922E-985F9D260157 @default.
- Q96132781 P31 Q96132781-6C14F4D3-0CB5-4F69-A35D-975D3FD4DC3A @default.
- Q96132781 P356 Q96132781-06FE982D-C9B4-4088-9448-E879FC8E7907 @default.
- Q96132781 P433 Q96132781-10D42AC0-10AE-48F7-B1A0-298CDCAE5918 @default.
- Q96132781 P478 Q96132781-B93C7154-458B-4D6E-92EB-88F75E995D99 @default.
- Q96132781 P577 Q96132781-58559869-EAAF-4C0B-91D3-02C1656CF37D @default.
- Q96132781 P698 Q96132781-1BBB48EB-E8B0-4F71-BCF7-BE9BADED60D9 @default.
- Q96132781 P921 Q96132781-4BD954DD-FF19-4285-87D7-0B0AC8F7A935 @default.
- Q96132781 P356 J.JAIP.2020.04.002 @default.
- Q96132781 P698 32499036 @default.
- Q96132781 P1433 Q24056070 @default.
- Q96132781 P1476 "Evidence Accumulates Against Angiotensin-Converting Enzyme Inhibitors and Beta-Adrenergic Blockers as Important Co-factors for Anaphylactic Reactions" @default.
- Q96132781 P2093 "Paul A Greenberger" @default.
- Q96132781 P304 "1906-1907" @default.
- Q96132781 P31 Q13442814 @default.
- Q96132781 P356 "10.1016/J.JAIP.2020.04.002" @default.
- Q96132781 P433 "6" @default.
- Q96132781 P478 "8" @default.
- Q96132781 P577 "2020-06-01T00:00:00Z" @default.
- Q96132781 P698 "32499036" @default.
- Q96132781 P921 Q168800 @default.